Alison Moore, Chief Technical Officer at Allogene Therapeutics, Inc. (ALLO), sold 92,397 shares at $32.00 ($3.0M) on 2019-09-16, disclosed to the SEC on 2019-09-18.
Open-market sale of $3.0M ALLO by Chief Technical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.00 | 5,257 | $168K | 5.7% |
| 2 | $32.11 | 22,503 | $723K | 24.4% |
| 3 | $32.11 | 22,503 | $723K | 24.4% |
| 4 | $32.13 | 21,067 | $677K | 22.8% |
| 5 | $32.13 | 21,067 | $677K | 22.8% |
| Total | $32.11 avg | 92,397 |
| $3.0M |
| 100% |
| Filing → |
| CDXS | SELL | 2025-10-15 | $16K | — | Filing → |
| ALLO | SELL | 2022-03-17 | $133K | — | Filing → |
| ALLO | SELL | 2021-03-17 | $470K | — | Filing → |